Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

(NY: BALL )

59.01 -0.24 (-0.41%)
Official Closing Price Updated: 7:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about BALL

< Previous 1 2 3 4 Next >
Albemarle To $440? Here Are 5 Other Price Target Changes For Monday
Oppenheimer boosted Albemarle Corporation (NYSE: ALB) price target from $368 to $440. However, Oppenheimer analyst Colin Rusch maintained an Outperform rating on the stock. Albemarle shares rose 1.5%... 
Via Benzinga
U.S. Stock Futures Higher After Friday's Jobs Report
Pre-open movers 
Via Benzinga
Ball Corp Hit With Downgrades, Price Target Cuts Post Q2 Results
Via Benzinga
Clorox, Crocs And Some Other Big Stocks Moving Lower On Thursday
  AMTD Digital Inc. (NYSE: HKD) dipped 43.6% to $620.00 on possible profit taking after the stock surged over the last few trading days. 
Via Benzinga
Wood Mackenzie, Ball Launch New Analytics Tool For Energy Markets
Via Benzinga
Ball Aerospace Picks Rocket Lab To Power NASA's GLIDE Spacecraft
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
  On Friday, 72 companies set new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
  On Thursday, 49 companies reached new 52-week lows. 
Via Benzinga
Ball Partners With Manna Capital - Read Why
Via Benzinga
Ball Corp Inks Power Purchase Agreement For New Wind Energy
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 5, 2022
Upgrades 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 4, 2022
Upgrades 
Via Benzinga
Why NanoViricides Jumped Over 48%; Here Are 106 Biggest Movers From Yesterday
Gainers ChemoCentryx, Inc. (NASDAQ: CCXI) surged 109.2% to settle at $50.43 on Thursday after the company, and Amgen, announced an agreement under which Amgen will acquire the company for $52 per share... 
Via Benzinga
What 4 Analyst Ratings Have To Say About Ball
Ball (NYSE:BALL) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Why ChemoCentryx Is Trading Higher By 110%, Here Are 95 Stocks Moving In Thursday's Mid-Day Session
Gainers InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) shares jumped 178.5% to $12.45 after gaining over 12% on Wednesday. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 9, 2022
Upgrades 
Via Benzinga
It’s a Market of Stocks Not a Stock Market
Stocks are as individual as people. What really matters, in the long run, is how well the business is operated, which will always be reflected in the fundamentals. 
Via Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For May 17, 2022
Via Benzinga
Stocks Pacing for Sizable Daily Wins, Steep Weekly Losses
Stocks are extending this morning's rally at midday, giving investors hope that Wall Street could finally be bouncing back from this week's selloff. 
Via Talk Markets
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.